Question special
Lead Moderator

As the NIH budget was negatively impacted by the sequestration and budget cuts in recent years, many researchers have had to turn to other sources for funding. However, the House of Representatives recently passed the 21st Century Cures Act, which has the potential to give the NIH budget an additional $8.75 billion over five years. Does this bill, which garnered strong bipartisan support, represent a turning point for research funding? Do you foresee a sustained impact on the funding climate or is this a short-term bandage? How will this legislature directly impact physician-scientists, both in the arena of funding and in the proposed changes for the FDA?